Evidence map›Paper›PMID 29259493›Full record

ArticleReproductive medicine and biology2017

Gamma-aminobutyric acid

Haruhiko Kanasaki, Tuvshintugs Tumurbaatar, Aki Oride, Tomomi Hara, Hiroe Okada, Satoru Kyo

Open access · goldAbstract read
In one paragraph

Article in Reproductive medicine and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Intricate Connections between the Microbiota and Endometriosis.International journal of molecular sciences · 2021
    Review
  5. Gamma-aminobutyric acidReproductive medicine and biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Haruhiko KanasakiDepartment of Obstetrics and Gynecology Shimane University School of Medicine Izumo Japan.ORCID 0000-0001-7011-8109
Tuvshintugs TumurbaatarDepartment of Obstetrics and Gynecology Shimane University School of Medicine Izumo Japan.
Aki OrideDepartment of Obstetrics and Gynecology Shimane University School of Medicine Izumo Japan.ORCID 0000-0001-6609-2487
Tomomi HaraDepartment of Obstetrics and Gynecology Shimane University School of Medicine Izumo Japan.
Hiroe OkadaDepartment of Obstetrics and Gynecology Shimane University School of Medicine Izumo Japan.
Satoru KyoDepartment of Obstetrics and Gynecology Shimane University School of Medicine Izumo Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Accumulating evidence indicates that hypothalamic kisspeptin plays a pivotal role in the regulation of the hypothalamic-pituitary-gonadal (HPG) axis. In this study, the direct action of the gamma-aminobutyric acid (GABA) Methods: A hypothalamic cell model of rat hypothalamic cell line R8 (rHypoE8) cells and primary cultures of neuronal cells from fetal rat brains were stimulated with a potent and selective GABA Results: Stimulation of the rHypoE8 cells with muscimol significantly increased the level of KiSS-1 messenger (m)RNA expression. The ability of muscimol to increase the level of KiSS-1 mRNA also was observed in the primary cultures of the neuronal cells from the fetal rat brains. The muscimol-induced increase in KiSS-1 mRNA expression was completely inhibited in the presence of the GABA Conclusions: This study's observations suggest that the activation of the GABA

Indexed as

gamma‐aminobutyric acidA receptorgonadotropin‐releasing hormonehypothalamuskisspeptinmuscimol

Identifiers

PMID29259493
PMCPMC5715903
OpenAlexW2761343629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.